Clinical trials
Volunteers clinical trials
Below are recruiting volunteers clinical trials, each written for real people, not researchers. We’re tracking 528 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07439796RecruitingPhase 1
Study of ORN252 in healthy volunteers
This trial tests a new medicine called ORN252 in healthy people to see how safe it is. It helps researchers understand how the drug works before testing it in patients.
Herston, QueenslandAges 18–55 - NCT07449741RecruitingPhase 1
Early safety test of HXN6005 in healthy adults
This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.
Bayswater, VictoriaAges 18–55 - NCT07455994Recruiting
Autonomic nervous system changes in children with type 1 diabetes
This study looks at how the autonomic nervous system (which controls automatic functions like heart rate) works in children with type 1 diabetes compared to children without diabetes. It may help understand if diabetes affects these automatic functions.
Saint-EtienneAges 1–17 - NCT07470671Recruiting
Study of healthy knees in Caucasian adults
This trial studies the knees of healthy Caucasian adults aged 20 to 35. It helps researchers understand normal knee structure and function.
Leuven, Vlaams-BrabantAges 20–35 - NCT07471932RecruitingPhase 1
Testing a new skin medicine in healthy adults
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
LeidenAges 18–45 - NCT07476586RecruitingPhase 1
Study of GenSci161 safety in healthy adults
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07660731RecruitingPhase 1
Testing a new asthma medicine in healthy people and those with asthma
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
New Haven, ConnecticutAges 18–65 - NCT07495202RecruitingPhase 1
Monkeypox vaccine trial for healthy adults
This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.
Shenzhen, GuangdongAges 18–59 - NCT07504003Recruiting
How exercise session length affects your body's resilience
This study looks at how the length of your exercise sessions affects your body's ability to adapt and get stronger over time. It's designed for people who are already active but not training more than 2 hours a week.
Saint-EtienneAges 18–45 - NCT07514260RecruitingPhase 1
Safety study of ABBV-295 injections in Japanese adults with overweight
This is an early-stage safety study testing a new injectable medication (ABBV-295) in healthy Japanese adults who are overweight or have obesity. The study measures how well the body tolerates the drug and how it moves through the body.
Anaheim, CaliforniaAges 18–65 - NCT07514780RecruitingPhase 1
Safety study of JW0061 in healthy adults
This is an early-stage safety test of a new drug called JW0061 in people without serious health conditions. Researchers will monitor how your body processes the drug and any side effects that occur.
Seoul, SeoulAges 19–55 - NCT07516405RecruitingPhase 1
Psilocybin Safety Study in Older Adults
This research tests whether psilocybin (a psychoactive compound from certain mushrooms) is safe and well-tolerated in healthy people aged 65–85. Researchers want to understand how older adults respond to this substance and whether it could be useful for future treatments.
San Francisco, CaliforniaAges 65–85 - NCT07521189Recruiting
How Diet Type Affects Protein Digestion in Young and Older Adults
This study compares how well the body digests protein from plant-based versus meat-based diets in young adults (18–23) and older adults (65–75). Researchers want to understand if age and diet type affect how efficiently your body uses protein from food.
BobignyAges 18–75 - NCT07522970RecruitingPhase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07525947RecruitingPhase 1
Safety Study of JADE101 in Healthy Japanese and Chinese Adults
This is an early-stage safety study of an experimental medicine called JADE101. Researchers want to give a single dose to healthy volunteers of Japanese or Chinese heritage to see how the body handles it and watch for any side effects.
Glendale, CaliforniaAges 18–55 - NCT07526519RecruitingPhase 1
Safety study of TL-003 for healthy adults and ulcerative colitis
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
Perth, Western AustraliaAges 18–55 - NCT07527923RecruitingPhase 1
Testing REGN20423 for healthy people and atopic dermatitis
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
Leuven, Vlaams-BrabantAges 18–65 - NCT07544875Recruiting
Brain Training Program for Adults in Hong Kong
This volunteer training program in Hong Kong teaches brain exercises and cognitive skills to adults age 50 and older. The program aims to help keep your mind sharp and may improve memory and thinking abilities.
Hong KongAges 50 years+ - NCT07549919RecruitingPhase 1
Food Effects on a New Experimental Drug in Healthy Men
This study tests how food affects how the body absorbs and processes a new experimental drug called AJ201. Researchers will give the drug to healthy men with and without food to see if it makes a difference, and they'll check for any side effects.
Los Alamitos, CaliforniaAges 18–55 - NCT07554222RecruitingPhase 1
Safety study of IBI3013 for vitiligo and hair loss
This is an early-stage safety study of a new drug called IBI3013. The trial tests how safe the drug is and how your body processes it. It enrolls healthy volunteers first, then people with vitiligo (loss of skin color) or severe alopecia areata (patchy hair loss).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07554365RecruitingPhase 1
Safety Study of AN01 Inhaled Powder in Healthy Adults
This early-stage trial tests whether AN01, a new inhaled powder medication, is safe and well-tolerated in healthy people. Researchers will measure how the body processes the drug and watch for any side effects.
Adelaide, South AustraliaAges 18–60 - NCT07555574Recruiting
New imaging technology to see retinal structures clearly
This research study tests a new camera technology that takes detailed pictures of the back of your eye (retina) to better understand eye diseases. Researchers want to compare images from people with eye conditions like diabetes-related eye disease, glaucoma, or age-related macular degeneration with healthy volunteers to see how the new imaging works.
Melbourne, VictoriaAges 18 years+ - NCT07565493RecruitingEarly Phase 1
Psilocybin with a serotonin blocker in healthy adults
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
Baltimore, MarylandAges 21–60 - NCT07566572RecruitingPhase 1
Safety Study of BGM0504 Tablets in Healthy Chinese Adults
This is an early-stage safety study testing a new tablet called BGM0504 in healthy volunteers. Researchers want to understand how the body handles this drug and check for any side effects.
Hangzhou, ZhejiangAges 18–55
Hear when a new Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for volunteers?
- Yes. Clin2 currently lists 528 recruiting volunteers studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a volunteers trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a volunteers trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.